UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Disruption of Rab3-calmodulin interaction, but not other effector interactions, prevents Rab3 inhibition of exocytosis

The EMBO journal, 1999-11, Vol.18 (21), p.5885-5891

1999

Volltextzugriff (PDF)

Direct Interaction of the Rab3 Effector RIM with Ca2+Channels, SNAP-25, and Synaptotagmin

The Journal of biological chemistry, 2001-08, Vol.276 (35), p.32756-32762

2001

Volltextzugriff (PDF)

Leichte Sprache: Grundlagen, Diskussionen und Praxisfelder

1st ed., 2024

Volltextzugriff (PDF)

Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial

Bone marrow transplantation (Basingstoke), 2022-06, Vol.57 (6), p.990-997

2022

Volltextzugriff (PDF)

Bulk meltwater flow and liquid water content of snowpacks mapped using the electrical self-potential (SP) method

The cryosphere, 2016-02, Vol.10 (1), p.433-444

2016

Volltextzugriff (PDF)

CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency

Science (American Association for the Advancement of Science), 2016-03, Vol.351 (6278), p.1199-1203

2016

Volltextzugriff (PDF)

High-Dose Chemotherapy with Bendamustin and Melphalan Improves the Rate of Complete Remission in Myeloma Patients in First Remission Compared to Standard Melphalan Alone

Blood, 2020-11, Vol.136 (Supplement 1), p.39-40

2020

Volltextzugriff (PDF)

Repair, Brokenness, Breakthrough: Ethnographic Responses

1st edition., 2019

Volltextzugriff (PDF)

Effectiveness of bio-effectors on maize, wheat and tomato performance and phosphorus acquisition from greenhouse to field scales in Europe and Israel: a meta-analysis

Frontiers in plant science, 2024-04, Vol.15, p.1333249-1333249

2024

Volltextzugriff (PDF)

Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease

Neurobiology of disease, 2004-12, Vol.17 (3), p.455-461

2004

Volltextzugriff (PDF)

Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain

Human molecular genetics, 2002-08, Vol.11 (17), p.1911-1926

2002

Volltextzugriff (PDF)

Regional and cellular gene expression changes in human Huntington's disease brain

Human molecular genetics, 2006-03, Vol.15 (6), p.965-977

2006

Volltextzugriff (PDF)

HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation

Brain (London, England : 1878), 2014-03, Vol.137 (Pt 3), p.819-833

2014

Volltextzugriff (PDF)

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood

Proceedings of the National Academy of Sciences - PNAS, 2007-09, Vol.104 (36), p.14424-14429

2007

Volltextzugriff (PDF)

Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects

Human molecular genetics, 2002-08, Vol.11 (17), p.1927-1937

2002

Volltextzugriff (PDF)

Uncertainty Quantification in CNN-Based Surface Prediction Using Shape Priors

Shape in Medical Imaging, p.300-310

Volltextzugriff (PDF)

Modulation of nucleosome dynamics in Huntington's disease

Human molecular genetics, 2007-05, Vol.16 (10), p.1164-1175

2007

Volltextzugriff (PDF)

A Brain-Permeable Small Molecule Reduces Neuronal Cholesterol by Inhibiting Activity of Sirtuin 2 Deacetylase

ACS chemical biology, 2011-06, Vol.6 (6), p.540-546

2011

Volltextzugriff (PDF)

Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1

Human molecular genetics, 2005-01, Vol.14 (2), p.179-189

2005

Volltextzugriff (PDF)

Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data

BMC bioinformatics, 2006-04, Vol.7 (1), p.211-211, Article 211

2006

Volltextzugriff (PDF)

Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease

Human molecular genetics, 2002-08, Vol.11 (17), p.1939-1951

2002

Volltextzugriff (PDF)

Comparative Alcohol Concentrations in Blood and Vitreous Fluid With Illustrative Case Studies

Journal of analytical toxicology, 2005-07, Vol.29 (5), p.365-369

2005

Volltextzugriff (PDF)

Evaluation of a portable evidential breath alcohol analyzer

Forensic science international, 2005-10, Vol.153 (1), p.17-21

2005

Volltextzugriff (PDF)

Longitudinal expression changes are weak correlates of disease progression in Huntington’s disease

Brain communications, 2020-01, Vol.2 (2), p.fcaa172-fcaa172

2020

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disruption of Rab3-calmodulin interaction, but not other effector interactions, prevents Rab3 inhibition of exocytosis

Direct Interaction of the Rab3 Effector RIM with Ca2+Channels, SNAP-25, and Synaptotagmin

Leichte Sprache: Grundlagen, Diskussionen und Praxisfelder

Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial

Bulk meltwater flow and liquid water content of snowpacks mapped using the electrical self-potential (SP) method

CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency

High-Dose Chemotherapy with Bendamustin and Melphalan Improves the Rate of Complete Remission in Myeloma Patients in First Remission Compared to Standard Melphalan Alone

Repair, Brokenness, Breakthrough: Ethnographic Responses

Effectiveness of bio-effectors on maize, wheat and tomato performance and phosphorus acquisition from greenhouse to field scales in Europe and Israel: a meta-analysis

Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease

Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain

Regional and cellular gene expression changes in human Huntington's disease brain

HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood

Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects

Uncertainty Quantification in CNN-Based Surface Prediction Using Shape Priors

Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage

Modulation of nucleosome dynamics in Huntington's disease

A Brain-Permeable Small Molecule Reduces Neuronal Cholesterol by Inhibiting Activity of Sirtuin 2 Deacetylase

Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1

Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data

Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease

Comparative Alcohol Concentrations in Blood and Vitreous Fluid With Illustrative Case Studies

Evaluation of a portable evidential breath alcohol analyzer

Longitudinal expression changes are weak correlates of disease progression in Huntington’s disease

Suchergebnisse filtern